331465-71-5,
2,8,9-Triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane,
Triisobutylphosphatrane,
2,8,9-Triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane, 97%,
MFCD03840347,
ACMC-1BMUP,
AC1ND8GU,
[Nitrilotrisethylenetris(isobutylimino)]phosphine,
SCHEMBL139612,
CTK8C6089,
DTXSID90404376,
WFHPXSHLCFHEIA-UHFFFAOYSA-N,
ZINC2513220,
AKOS015912887,
4,6,11-tris(2-methylpropyl)-1,4,6,11-tetraza-5-phosphabicyclo[3.3.3]undecane,
KS-0000191E,
AK669516,
RT-018559,
I14-48396,
2,8,9-Tri-i-butyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3] undecane,
2,8,9-tri-i-butyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane,
2,8,9-triisobutyl -2,5,8,9-tetraaza-1-phospha-bicyclo[3.3.3]undecane,
2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phospha-bicyclo[3.3.3]undecane,
2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo-[3.3.3]undecane,
2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3] undecane,
2,8,9-Triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane solution,
2,8,9-Tris(2-methylpropyl)-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane,
2,8,9-tris(2-methylpropyl)-2,5,8,9-tetraza-1-phosphabicyclo[3.3.3]undecane,
2,8,9-Triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane solution, 0.5 M in diethyl ether,
CID4571243,
2,8,9-Triisobutyl-2,5,8,9-tetraaza-1- phosphabicyclo[3.3.3]undecane,